chr16-16048222-G-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004996.4(ABCC1):​c.1299G>T​(p.Arg433Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 1,614,196 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0075 ( 8 hom., cov: 32)
Exomes 𝑓: 0.012 ( 131 hom. )

Consequence

ABCC1
NM_004996.4 missense

Scores

4
9
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: -0.0320

Publications

44 publications found
Variant links:
Genes affected
ABCC1 (HGNC:51): (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra-and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This full transporter is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions as a multispecific organic anion transporter, with oxidized glutatione, cysteinyl leukotrienes, and activated aflatoxin B1 as substrates. This protein also transports glucuronides and sulfate conjugates of steroid hormones and bile salts. Alternatively spliced variants of this gene have been described but their full-length nature is unknown. [provided by RefSeq, Apr 2012]
ABCC1 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 77
    Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019949764).
BP6
Variant 16-16048222-G-T is Benign according to our data. Variant chr16-16048222-G-T is described in ClinVar as Benign. ClinVar VariationId is 489391.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1149 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC1NM_004996.4 linkc.1299G>T p.Arg433Ser missense_variant Exon 10 of 31 ENST00000399410.8 NP_004987.2 P33527-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC1ENST00000399410.8 linkc.1299G>T p.Arg433Ser missense_variant Exon 10 of 31 1 NM_004996.4 ENSP00000382342.3 P33527-1

Frequencies

GnomAD3 genomes
AF:
0.00755
AC:
1149
AN:
152192
Hom.:
8
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00171
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.00386
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0124
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00890
AC:
2221
AN:
249556
AF XY:
0.00862
show subpopulations
Gnomad AFR exome
AF:
0.00155
Gnomad AMR exome
AF:
0.00417
Gnomad ASJ exome
AF:
0.0131
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0107
Gnomad NFE exome
AF:
0.0137
Gnomad OTH exome
AF:
0.00858
GnomAD4 exome
AF:
0.0117
AC:
17119
AN:
1461886
Hom.:
131
Cov.:
32
AF XY:
0.0114
AC XY:
8269
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.00206
AC:
69
AN:
33480
American (AMR)
AF:
0.00436
AC:
195
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
338
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00260
AC:
224
AN:
86258
European-Finnish (FIN)
AF:
0.0111
AC:
594
AN:
53420
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.0136
AC:
15079
AN:
1112006
Other (OTH)
AF:
0.00988
AC:
597
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
995
1990
2986
3981
4976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
560
1120
1680
2240
2800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00754
AC:
1149
AN:
152310
Hom.:
8
Cov.:
32
AF XY:
0.00681
AC XY:
507
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00171
AC:
71
AN:
41568
American (AMR)
AF:
0.00386
AC:
59
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
41
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4822
European-Finnish (FIN)
AF:
0.00942
AC:
100
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0124
AC:
843
AN:
68030
Other (OTH)
AF:
0.00568
AC:
12
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0112
Hom.:
36
Bravo
AF:
0.00691
TwinsUK
AF:
0.00971
AC:
36
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00168
AC:
7
ESP6500EA
AF:
0.0122
AC:
103
ExAC
AF:
0.00937
AC:
1134
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0116
EpiControl
AF:
0.0119

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCC1: BS1, BS2 -

Aug 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.59
D;T
Eigen
Uncertain
0.29
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Pathogenic
0.98
D;D
MetaRNN
Benign
0.020
T;T
MetaSVM
Uncertain
0.43
D
MutationAssessor
Uncertain
2.7
M;.
PhyloP100
-0.032
PrimateAI
Uncertain
0.75
T
PROVEAN
Pathogenic
-5.1
D;.
REVEL
Uncertain
0.64
Sift
Uncertain
0.0010
D;.
Sift4G
Pathogenic
0.0010
D;D
Polyphen
1.0
D;.
Vest4
0.93
MutPred
0.29
Loss of catalytic residue at R433 (P = 0.1193);.;
MVP
0.93
MPC
1.1
ClinPred
0.044
T
GERP RS
-0.26
Varity_R
0.86
gMVP
0.97
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60782127; hg19: chr16-16142079; COSMIC: COSV104658482; API